CYTK
Cytokinetics Inc
$85.26
2.07 (2.37%) Today
0.07 (0.08%) After-hours
— up— down
Market Cap
$10.60B+157.8%
Revenue (TTM)
$116.38M+450.6%
Net Income (TTM)
$-927,719,708
$-927,719,708EPS (TTM)
-6.84
-6.84Shares Out
135.58M
135.58MOpen
$87.77
$87.77Previous Close
$87.26
$87.26Day Range
$84.89 – $88.31
$84.89 – $88.3152-Week Range
$32.66 – $88.31
$32.66 – $88.31Beta
0.32
0.32Volume
2.40M
2.40MAvg Volume
2.42M
2.42MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout CYTK
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
Related
News
N/AN/AN/AN/A
Is Cytokinetics, Incorporated (CYTK) A Good Stock To Buy Now?
Yahoo · 1d ago
Cytokinetics Seen Gaining From Myqorzo Momentum to Treat Heart Conditions, UBS Says
Yahoo · 1d ago
UBS Upgrades Cytokinetics to Buy, Raises Price Target to $115
Benzinga · 1d ago
Mizuho Maintains Outperform on Cytokinetics, Raises Price Target to $118
Benzinga · 6d ago